| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.5M | +120.5% |
| Cost of Revenue | $2.8M | +116.4% |
| Gross Profit | $1.7M | +127.5% |
| R&D Expense | $150K | +157.9% |
| SG&A Expense | $8.0M | -2.9% |
| Operating Income | -$43.8M | -467.7% |
| Pre-tax Income | -$43.8M | -489.4% |
| Income Tax | $0 | -100.0% |
| Net Income | -$43.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -42.9% |
| Short-term Investments | $2.3M | -70.8% |
| Accounts Receivable | $2.1M | +45.2% |
| Inventory | $5.7M | +47.3% |
| Current Assets | $18.3M | -20.3% |
| Total Assets | $33.5M | -55.5% |
| Current Liabilities | $1.5M | -5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +42.6% |
| Capital Expenditures | $169K | +503.0% |
| Investing Cash Flow | $5.5M | +217.7% |
| Financing Cash Flow | -$157K | -100.8% |
| Free Cash Flow | -$7.6M | +41.4% |
| -472.4% |
| EPS (Basic) | -$2.92 | -335.8% |
| Total Liabilities |
| $1.5M |
| -4.9% |
| Stockholders' Equity | $32.0M | -56.6% |